Correlation Between Leap Therapeutics and Akebia Ther
Can any of the company-specific risk be diversified away by investing in both Leap Therapeutics and Akebia Ther at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Leap Therapeutics and Akebia Ther into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Leap Therapeutics and Akebia Ther, you can compare the effects of market volatilities on Leap Therapeutics and Akebia Ther and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Leap Therapeutics with a short position of Akebia Ther. Check out your portfolio center. Please also check ongoing floating volatility patterns of Leap Therapeutics and Akebia Ther.
Diversification Opportunities for Leap Therapeutics and Akebia Ther
-0.58 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Leap and Akebia is -0.58. Overlapping area represents the amount of risk that can be diversified away by holding Leap Therapeutics and Akebia Ther in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akebia Ther and Leap Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Leap Therapeutics are associated (or correlated) with Akebia Ther. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akebia Ther has no effect on the direction of Leap Therapeutics i.e., Leap Therapeutics and Akebia Ther go up and down completely randomly.
Pair Corralation between Leap Therapeutics and Akebia Ther
Given the investment horizon of 90 days Leap Therapeutics is expected to under-perform the Akebia Ther. In addition to that, Leap Therapeutics is 3.84 times more volatile than Akebia Ther. It trades about -0.4 of its total potential returns per unit of risk. Akebia Ther is currently generating about 0.24 per unit of volatility. If you would invest 179.00 in Akebia Ther on November 9, 2024 and sell it today you would earn a total of 37.00 from holding Akebia Ther or generate 20.67% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Leap Therapeutics vs. Akebia Ther
Performance |
| Timeline |
| Leap Therapeutics |
| Akebia Ther |
Leap Therapeutics and Akebia Ther Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Leap Therapeutics and Akebia Ther
The main advantage of trading using opposite Leap Therapeutics and Akebia Ther positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Leap Therapeutics position performs unexpectedly, Akebia Ther can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akebia Ther will offset losses from the drop in Akebia Ther's long position.| Leap Therapeutics vs. X4 Pharmaceuticals | Leap Therapeutics vs. Terns Pharmaceuticals | Leap Therapeutics vs. Day One Biopharmaceuticals | Leap Therapeutics vs. PDS Biotechnology Corp |
| Akebia Ther vs. Protalix Biotherapeutics | Akebia Ther vs. Cidara Therapeutics | Akebia Ther vs. X4 Pharmaceuticals | Akebia Ther vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Global Correlations Find global opportunities by holding instruments from different markets |